help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 26, 2005
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2004-2184
A more recent version of this article appeared on July 1, 2005
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
90/7/4108    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cocco, C.
Right arrow Articles by Ferri, G.-L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cocco, C.
Right arrow Articles by Ferri, G.-L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Submitted on November 5, 2004
Accepted on April 15, 2005

MEDIAN EMINENCE DOPAMINERGIC NERVE TERMINALS, A NOVEL TARGET IN AUTOIMMUNE POLYENDOCRINE SYNDROME?

Cristina Cocco PhD, Antonella Meloni MD, Francesco Boi MD, Giovanni Pinna MD, Roberta Possenti BSc, Stefano Mariotti MD, and Gian-Luca Ferri MD*

NEF-Laboratory, Dept. Cytomorphology, and Endocrinology, Dept. Medical Science, University of Cagliari at Monserrato, Monserrato (Cagliari), Italy; Clinica Pediatrica II, Dept. Biomedical Biotechnological Science, University of Cagliari, Cagliari, Italy; Dept. Neuroscience, Tor Vergata University, Rome, Italy

* To whom correspondence should be addressed. E-mail: ferri{at}unica.it.

Context. Autoantibodies to adenohypophyseal endocrine cells, or to vasopressin neurohypophyseal neurons have long been known. Conversely, autoimmune targeting of further hypothalamic-hypophyseal structures, such as the blood-brain barrier deprived median eminence has been little studied.

Objective and methods. We studied a case of autoimmune polyendocrine syndrome type I (APS I) with GH secretory deficiency, a distinctly rare event in APS I. We used rat and bovine tissue substrates to study autoantibodies against hypothalamic-hypophyseal nerve structures and endocrine cells.

Results. In the study case, circulating autoantibodies selectively decorated median eminence dopaminergic nerve terminals, as well as pituitary gonadotropes, but not GHRH-nerve terminals, nor pituitary somatotropes. Such autoantibodies appeared de novo in parallel with the onset of GH secretory deficiency, while no median eminence labeling was found in patients suffering of idiopathic GH deficiency (n = 7), nor in healthy controls (n = 23).

Conclusions. The pathophysiological significance of our patient's autoantibodies remains to be confirmed. None the less, the heterogeneous neuroendocrine structures of the median eminence are pointed out as potential immune targets, relevant to autoimmune polyendocrinopathy, as well as to a wide range of other conditions.


Key words: hypothalamus • median eminence • pituitary • dopamine • autoimmunity • APS I • APECED




This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
A. De Bellis, F. Kelestimur, A. Agostino Sinisi, G. Ruocco, G. Tirelli, M. Battaglia, G. Bellastella, G. Conzo, F. Tanriverdi, K. Unluhizarci, et al.
Anti-hypothalamus and anti-pituitary antibodies may contribute to perpetuate the hypopituitarism in patients with Sheehan's syndrome
Eur. J. Endocrinol., February 1, 2008; 158(2): 147 - 152.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. Bensing, S. O. Fetissov, J. Mulder, J. Perheentupa, J. Gustafsson, E. S. Husebye, M. Oscarson, O. Ekwall, P. A. Crock, T. Hokfelt, et al.
Pituitary autoantibodies in autoimmune polyendocrine syndrome type 1
PNAS, January 16, 2007; 104(3): 949 - 954.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society